Modeling and simulation in pediatric drug development Article Modeling and simulation in pediatric drug development Published: 2023 年 12 月 21 日 This is the article written in German, published on pharmind.Children's…Certara2023 年 12 月 21 日
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Case Study 转化药理学咨询支持治疗肺分枝杆菌复合病的联合疗法 RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…Danielle Pillsbury2023 年 5 月 9 日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges On-Demand Webinar 治疗蛋白质的药物间相互作用:最新情况与挑战 Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…Becca Bucci2022 年 12 月 5 日
Why you should select your drug formulation before starting clinical studies Blog 为何应在开始临床研究前选择药物制剂 药物开发者常急于推进发现流程以进入人体试验。Most are…Certara2022 年 10 月 28 日
3 Takeaways from the FDA Oligo Guidance You Need to Know Blog 3 Takeaways from the FDA Oligo Guidance You Need to Know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…Certara2022 年 9 月 23 日
The Essential Components of Your Drug’s Biomarker Strategy White Paper The Essential Components of Your Drug’s Biomarker Strategy Jim Gallagher2022 年 1 月 14 日
Predicting and Taming Immunogenicity: Strategies for your Biologic Drug On-Demand Webinar 预测和驯化免疫原性:生物药物策略 Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…Jim Gallagher2021 年 11 月 19 日
Dose Optimization Using Population PK for an Orphan Drug Case Study Dose Optimization Using Population PK for an Orphan Drug RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…Jim Gallagher2021 年 11 月 17 日
A Day in the Life of a Clinical Pharmacology Consultant Blog 临床药理学顾问的日常一天 Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…Certara2021 年 10 月 8 日
Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Blog Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Alzheimer's disease (AD) is one of the most common forms of neurodegenerative dementia in the…Certara2021 年 9 月 20 日